论文部分内容阅读
目的 通过对 16例晚期贲门癌的临床追踪分析 ,以探讨其手术指征和疗效。方法 1988年 3月至 1996年 6月对 16例贲门癌由于与其它脏器粘连浸润而行联合脏器切除 ,其中贲门癌合并肝左外叶切除 4例 ,合并脾切除 2例 ,合并胰体尾、脾切除 10例。结果 全组无手术死亡 ,无吻合口瘘 ,术后并发症发生率为 18.8% ( 3 / 16) ,均治愈 ,根治性切除 1、3、5年生存率分别为 5 0 %、2 5 %、12 .5 % ,姑息性切除均在半年内死亡。结论 贲门癌粘连浸润其它脏器应争取根治性切除 ,不能根治性切除者 ,应尽量避免进行复合脏器切除
Objective To investigate the clinical indications and efficacy of 16 cases of advanced cardial cancer by clinical follow-up analysis. METHODS: From March 1988 to June 1996, 16 cases of cardiac cancer were treated with combined organ infiltration due to adhesion with other organs. Among them, cardiac cancer with left hepatic lobectomy in 4 cases, splenectomy in 2 cases, and pancreatic body merger. Tail and splenectomy were performed in 10 cases. Results There was no operative death and no anastomotic leakage in the whole group. The postoperative complication rate was 18.8% (3 / 16). Both were cured. The 1-, 3-, and 5-year survival rates of radical resection were 50% and 25% respectively. 12.5% of palliative resections died within six months. Conclusion Cardiac cancer infiltration of other organs should strive for radical resection. Those who cannot undergo radical resection should avoid complicated organ resection.